Review



mitogen activated protein kinase mapk pathway inhibitors  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    TargetMol mitogen activated protein kinase mapk pathway inhibitors
    Mitogen Activated Protein Kinase Mapk Pathway Inhibitors, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mapk+pathway/MAPK+Inhibitor+Library/pm41998662-70-33-42
    Average 94 stars, based on 10 article reviews
    mitogen activated protein kinase mapk pathway inhibitors - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Proliferation Assay:

    Article Title: The role of DNAJC3 in enhancing glioma progression and regulating the tumor immune microenvironment.
    Article Snippet: 4.7 Cell Proliferation assay Cell viability was assessed using the CCK-8 assay (TargetMol, China). .. 4.7 Cell Proliferation assay Cell viability was assessed using the CCK-8 assay (TargetMol, China). ..

    CCK-8 Assay:

    Article Title: The role of DNAJC3 in enhancing glioma progression and regulating the tumor immune microenvironment.
    Article Snippet: 4.7 Cell Proliferation assay Cell viability was assessed using the CCK-8 assay (TargetMol, China). .. 4.7 Cell Proliferation assay Cell viability was assessed using the CCK-8 assay (TargetMol, China). ..

    Drug discovery:

    Article Title: AR/ERK co-targeting triggers ferroptosis via FOXC2 in triple-negative breast cancer.
    Article Snippet: 1Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China 2Department of Breast Surgery, Peking Union Medical College Hospital, Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China 3Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou 215000, China 4The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China 5Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming 650223, China 6Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China

    Western Blot:

    Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
    Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..

    Transduction:

    Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
    Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..

    Control:

    Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
    Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..

    Concentration Assay:

    Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
    Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..

    Phospho-proteomics:

    Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
    Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..

    Expressing:

    Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
    Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..

    other:

    Article Title: MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.
    Article Snippet: A range of reagents was procured from various suppliers, including KRAS G12C inhibitors such as fulzerasib (#T73190, TargetMol, Boston, Massachusetts, USA), garsorasib (#E1578, Selleck, Shanghai, China), sotorasib (#T8684, TargetMol), and adagrasib (#T8369, TargetMol); Mitogen-activated protein kinase (MAPK) pathway inhibitors including trametinib (#T2125, TargetMol) and SCH772984 (#T6066, AR TIC LE IN PR ES S TargetMol); the pan-RAS inhibitor RMC-7977 (#T81263, TargetMol); ferroptosis inducers, including RSL3 (#R302648, Aladdin, Shanghai, China) and Imidazole ketone erastin (IKE) (#T5523, TargetMol); as well as other inhibitors of cell death such as ferrostatin-1 (fer-1) (#T6500, TargetMol), deferoxamine (DFO) (#T1637, TargetMol), Z-VAD-FMK (Z-VAD) (#T7020, TargetMol), and necrosulfonamide (necro) (#T6904, TargetMol).



    Similar Products

    94
    MedChemExpress mitogen activated protein kinase mapk signaling pathway
    Mitogen Activated Protein Kinase Mapk Signaling Pathway, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mapk+pathway/PD318088/10__34133_slash_cancomm__0048-53-7-23
    Average 94 stars, based on 1 article reviews
    mitogen activated protein kinase mapk signaling pathway - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    RayBiotech inc mouse mapk pathway phosphorylation array c1
    Mouse Mapk Pathway Phosphorylation Array C1, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mapk+pathway/Human+and+Mouse+AKT+Pathway+Phosphorylation+Array+C1/pm42468084-162-10-16
    Average 95 stars, based on 1 article reviews
    mouse mapk pathway phosphorylation array c1 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    MedChemExpress mapk pathway inhibitor u0126
    Mapk Pathway Inhibitor U0126, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mapk+pathway/U0126-EtOH/pm42287485-49-9-17
    Average 96 stars, based on 1 article reviews
    mapk pathway inhibitor u0126 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    86
    Jordi Labs mitogen activated protein kinase mapk pathway
    Mitogen Activated Protein Kinase Mapk Pathway, supplied by Jordi Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mapk+pathway/activated+kinase+mapk+mitogen+pathway+protein/pm42149426-43-1-16
    Average 86 stars, based on 1 article reviews
    mitogen activated protein kinase mapk pathway - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    TargetMol mitogen activated protein kinase mapk pathway inhibitors
    Mitogen Activated Protein Kinase Mapk Pathway Inhibitors, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mapk+pathway/MAPK+Inhibitor+Library/pm41998662-70-33-42
    Average 94 stars, based on 1 article reviews
    mitogen activated protein kinase mapk pathway inhibitors - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    98
    MedChemExpress mapk erk pathway inhibitors sch772984 hy 50846 ac ce pt ed m
    Mapk Erk Pathway Inhibitors Sch772984 Hy 50846 Ac Ce Pt Ed M, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mapk+pathway/SCH772984/pm41988986-311-14-43
    Average 98 stars, based on 1 article reviews
    mapk erk pathway inhibitors sch772984 hy 50846 ac ce pt ed m - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    97
    MedChemExpress p38 mapk pathway
    Oba inhibits the <t>TLR4/MyD88/p38</t> MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.
    P38 Mapk Pathway, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mapk+pathway/Phospho-p38+alpha%2FMAPK14+(Thr180%2BTyr182)+Antibody/pmc12994538-112-6-34
    Average 97 stars, based on 1 article reviews
    p38 mapk pathway - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc mapk pathway sampler kit
    Oba inhibits the <t>TLR4/MyD88/p38</t> MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.
    Mapk Pathway Sampler Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mapk+pathway/MAPK+Family+Antibody+Sampler+Kit/pm41831729-93-17-33
    Average 95 stars, based on 1 article reviews
    mapk pathway sampler kit - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc phospho mapk pathway sampler kit
    Oba inhibits the <t>TLR4/MyD88/p38</t> MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.
    Phospho Mapk Pathway Sampler Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mapk+pathway/Phospho-MAPK+Family+Antibody+Sampler+Kit/pm41831729-93-24-33
    Average 95 stars, based on 1 article reviews
    phospho mapk pathway sampler kit - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc p38 kinase pathway
    Oba inhibits the <t>TLR4/MyD88/p38</t> MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.
    P38 Kinase Pathway, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mapk+pathway/Phospho-p38+MAPK+(Thr180%2FTyr182)+Antibody/us12570711-1175-50-63
    Average 97 stars, based on 1 article reviews
    p38 kinase pathway - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    Image Search Results


    Oba inhibits the TLR4/MyD88/p38 MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.

    Journal: Drug Design, Development and Therapy

    Article Title: Obacunone Promotes Functional Recovery After Spinal Cord Injury by Attenuating Neuroinflammation by Targeting the TLR4/MyD88/p38 MAPK Pathway

    doi: 10.2147/DDDT.S577707

    Figure Lengend Snippet: Oba inhibits the TLR4/MyD88/p38 MAPK signaling pathway in both in vivo and in vitro experiments. ( A – D ) Molecular docking analysis of Oba with TLR4. ( E – H ) Molecular docking analysis of Oba with MyD88. ( I – L ) Molecular docking analysis of Oba with p38. For each protein, the analysis is presented as: an overall docking pose with the binding region outlined by a red dashed box ( A, E, I ); a close-up view of the binding region ( B, F, J ); a surface representation ( C, G, K ); and a two-dimensional interaction diagram ( D, H, L ). ( M ) Representative Western blot image of TLR4, MyD88, p-p38 and p38 protein in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, and 50 μM Oba. ( N ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in BV-2 cells (n = 5). ( O ) Western blot analysis of TLR4, MyD88, p-p38, and p38 in spinal cord tissues from Sham, SCI, and SCI + Oba (20 mg/kg) groups at 3 days post-SCI. ( P ) Quantitative analysis of TLR4 and MyD88 protein levels and p38 phosphorylation in spinal cord tissues (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.

    Article Snippet: To investigate the role of the p38 MAPK pathway in the anti-inflammatory effects of Oba, BV-2 cells were pre-treated for 3 hours with 50 μM Oba, 10 μM SB203580 (a p38 MAPK inhibitor; HY-10256, MCE, China), or a combination of both, prior to stimulation with LPS for 24 hours.

    Techniques: In Vivo, In Vitro, Binding Assay, Western Blot, Phospho-proteomics

    Oba attenuates inflammation by targeting the TLR4/MyD88/p38 MAPK pathway in BV-2 microglial cells. ( A ) Representative Western blot of TLR4 expression in BV-2 cells transfected with a TLR4 overexpression plasmid (pcDNA3.1-TLR4) or an empty vector. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: empty plasmid (Oe-NC), and TLR4 overexpression plasmid (Oe-TLR4). ( B ) Quantitative analysis of TLR4 protein levels (n = 5). ( C ) Western blot images of iNOS, TLR4, TNFα and IL-1β protein expression in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following treatments in culture: Oe-NC, Oe-TLR4, LPS, and Oba. ( D – G ) Quantitative analysis of iNOS, TLR4, TNFα and IL-1β protein levels (n = 5). ( H ) Representative Western blot images of iNOS, TNFα, IL-1β, p-p38 and p38 in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, Oba, and SB203580. ( I – L ) Quantitative analysis of iNOS, TNFα, IL-1β protein levels and p38 phosphorylation (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.

    Journal: Drug Design, Development and Therapy

    Article Title: Obacunone Promotes Functional Recovery After Spinal Cord Injury by Attenuating Neuroinflammation by Targeting the TLR4/MyD88/p38 MAPK Pathway

    doi: 10.2147/DDDT.S577707

    Figure Lengend Snippet: Oba attenuates inflammation by targeting the TLR4/MyD88/p38 MAPK pathway in BV-2 microglial cells. ( A ) Representative Western blot of TLR4 expression in BV-2 cells transfected with a TLR4 overexpression plasmid (pcDNA3.1-TLR4) or an empty vector. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: empty plasmid (Oe-NC), and TLR4 overexpression plasmid (Oe-TLR4). ( B ) Quantitative analysis of TLR4 protein levels (n = 5). ( C ) Western blot images of iNOS, TLR4, TNFα and IL-1β protein expression in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following treatments in culture: Oe-NC, Oe-TLR4, LPS, and Oba. ( D – G ) Quantitative analysis of iNOS, TLR4, TNFα and IL-1β protein levels (n = 5). ( H ) Representative Western blot images of iNOS, TNFα, IL-1β, p-p38 and p38 in BV-2 cells. The plus and minus signs (+, -) denote the presence or absence of the following reagents in culture: LPS, Oba, and SB203580. ( I – L ) Quantitative analysis of iNOS, TNFα, IL-1β protein levels and p38 phosphorylation (n = 5). The values are presented as mean ± SD. *p<0.05, **p<0.01, ***p<0.001; NS, not significant.

    Article Snippet: To investigate the role of the p38 MAPK pathway in the anti-inflammatory effects of Oba, BV-2 cells were pre-treated for 3 hours with 50 μM Oba, 10 μM SB203580 (a p38 MAPK inhibitor; HY-10256, MCE, China), or a combination of both, prior to stimulation with LPS for 24 hours.

    Techniques: Western Blot, Expressing, Transfection, Over Expression, Plasmid Preparation, Phospho-proteomics